FDA Avastin Hearing for Metastatic Breast Cancer News - Terry Kalley Testified at Hearing

Freedom of Access to Medicines is the top resource for all the latest news on the FDA Avastin Hearing!

• We are currently livetweeting every detail of the Hearing on FAMEDS Twitter.
• Posting the great number of articles from Media Outlets and having dialogue with supporters on our Facebook Page.
• FAMEDS has the Patient Protest/Rally Videos, Photos, the Speech Terry Kalley Testified, Slideshow Presented at the Hearing and more content on our Website Hearing Page.

Avastin Patient Series: Rachel Parrish & Husband Donald Parrish

Below is a living example of a Metastatic Breast Cancer Patient Surviving with the Drug Avastin! Check back to read every story in this continuing series!

If you are an Avastin patient or survivor, or family member, we encourage you to share your story! Email us with a video or written story describing your journey to Terry.Kalley@fameds.org

Avastin User Rachel Parrish's Story

Husband Donald Parrish's Story

Avastin Patient Series: Shannon's Story

Below is a living example of a Metastatic Breast Cancer Patient Surviving with the Drug Avastin! Check back to read every story in this continuing series!
If you are an Avastin Patient or Survivor, we encourage you to share your story! Email us with a video or article describing your journey to Terry.Kalley@fameds.org

Shannon's Story

via the South Charlotte Weekly in 3 Parts:

Page 1: http://fameds.org/pdf/morgan_1.pdf

Page 2: http://fameds.org/pdf/morgan_2.pdf

Page 3: http://fameds.org/pdf/morgan_3.pdf

Sign the Petition to Save the Avastin Women which will be Submitted to the FDA June 28, 2011!

PETITION TO PROTECT THE AVASTIN WOMEN READS:

I hereby urge the President of the United States of America, the Congress of the United States of America and the Commissioner of the Food and Drug Administration to act immediately to protect women with metastatic breast cancer (MBC), an incurable disease that kills 40,000 women per year.

We the People petition you to grandfather access to the drug Avastin for the current 17,500 patients, as well as protect their private insurance and Medicare coverage for Avastin. Without Avastin, women will die and without keeping their coverage intact through private insurance or Medicare, the drug will be unaffordable for most.

We further insist that you find ways to keep Avastin on the market for all patients who can benefit from its safe usage. We beg you to allow further trials for Avastin following FDA guidelines and to encourage further research to determine genetic markers for women who might benefit from Avastin.

We also implore you to explore ways to improve the FDA's drug approval process without reducing the safety of drugs reaching market.  The quicker patients have access to safe drugs, the more they can be helped.

We appeal to you to adopt common-sense approaches to allowing drug companies to donate drugs to people in need on a compassionate use basis.  Drug companies are restrained in donating on a compassionate use basis because of uncertainty of corporate and personal liability. This uncertainty must to be removed to help the needy.

We are a civilized society that values life. We also cherish individual freedom and the right of a patient to choose her medical options with her physician. By acting on this, you will confirm our belief that Life, Liberty and the Pursuit of Happiness is an inalienable right for all, including the seriously ill.

PLEASE SIGN HERE: http://fameds.org/petition.php

FAMEDS Featured on Detroit's ABC Affiliate WXYZ Channel 7 News

FAMEDS Founder Terry Kalley is Interviewed about his fight against the FDA in order to continue Avastin use for Metastatic Breast Cancer Patients, including his wife.

FDA Employees, Pharma and Bio Employees, Medical Advocacy Groups, Patients with Serious Illnesses, Other with interest in the Medical Community

Please comment and share your thoughts on the issue of the US FDA taking the Metastatic Breast Cancer Drug Avastin off label.

Is it the right decision or could it be handled differently?

How will this affect drug development in the U.S.?

Do you fear that this will slow development of other drugs for other serious illnesses?

What does this mean for our economic competitiveness in pharma and bio?

Is the FDA too harsh in its dealings with drug companies or does it need to crack down further on dangerous drugs reaching market?